Abbreviated Company Accounts - BILLAZE LIMITED

Abbreviated Company Accounts - BILLAZE LIMITED


Registered Number 01724065

BILLAZE LIMITED

Abbreviated Accounts

30 June 2015

BILLAZE LIMITED Registered Number 01724065

Abbreviated Balance Sheet as at 30 June 2015

Notes 2015 2014
£ £
Fixed assets
Intangible assets 2 132,734 141,029
Tangible assets 3 636,833 647,519
Investments 4 122,350 124,682
891,917 913,230
Current assets
Stocks 77,144 62,294
Debtors 543,075 515,696
Cash at bank and in hand 144,900 128,878
765,119 706,868
Creditors: amounts falling due within one year 5 (480,840) (331,270)
Net current assets (liabilities) 284,279 375,598
Total assets less current liabilities 1,176,196 1,288,828
Creditors: amounts falling due after more than one year 5 (386,708) (425,694)
Provisions for liabilities (37,632) (81,318)
Total net assets (liabilities) 751,856 781,816
Capital and reserves
Called up share capital 6 100 100
Profit and loss account 751,756 781,716
Shareholders' funds 751,856 781,816
  • For the year ending 30 June 2015 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
  • The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  • The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  • These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 31 March 2016

And signed on their behalf by:
K Rajani, Director

BILLAZE LIMITED Registered Number 01724065

Notes to the Abbreviated Accounts for the period ended 30 June 2015

1Accounting Policies

Basis of measurement and preparation of accounts
The accounts have been prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities effective April 2008.

Turnover policy
Turnover represents sale proceeds net of value added tax.

Valuation information and policy
Stocks
Stocks are stated at lower of cost and net realisable value established by independent valuers,
Messrs Essen Valuers who provide these services to the retail pharmaceutical industry. This is based on the stock take carried out by them.

2Intangible fixed assets
£
Cost
At 1 July 2014 210,983
Additions -
Disposals -
Revaluations -
Transfers -
At 30 June 2015 210,983
Amortisation
At 1 July 2014 69,954
Charge for the year 8,295
On disposals -
At 30 June 2015 78,249
Net book values
At 30 June 2015 132,734
At 30 June 2014 141,029
3Tangible fixed assets
£
Cost
At 1 July 2014 781,174
Additions 13,996
Disposals (45,650)
Revaluations -
Transfers -
At 30 June 2015 749,520
Depreciation
At 1 July 2014 133,655
Charge for the year 15,679
On disposals (36,647)
At 30 June 2015 112,687
Net book values
At 30 June 2015 636,833
At 30 June 2014 647,519

4Fixed assets Investments
Enterprise Zone Investment is included at cost less its depreciation.

5Creditors
2015
£
2014
£
Non-instalment debts due after 5 years 386,708 425,694
6Called Up Share Capital
Allotted, called up and fully paid:
2015
£
2014
£
100 Ordinary shares of £1 each 100 100